Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / IGC - India Globalization stock rises 10% on acquiring rights for potential Alzheimer's drug compound

IGC - India Globalization stock rises 10% on acquiring rights for potential Alzheimer's drug compound

India Globalization Capital Inc.
India Globalization Capital (NYSE:IGC) said it acquired exclusive global rights to a potential Alzheimer’s drug development candidate TGR-63 from India-based Jawaharlal Nehru Centre for Advanced Scientific Research. The company said JNCASR has developed Naphthalene Monoimide (NMI) compounds and have identified one lead NMI molecule, TGR 63, with the potential to reduce beta amyloid ((A?)) plaques. IGC added that in mouse model of Alzheimer's the molecule reduced cognitive decline. The company added that it plans to further develop the NMI lead candidate. IGC noted that IGC-AD1 is currently in human trials for neuropsychiatric symptoms associated with dementia in Alzheimer's. IGC +10.34% to $0.64 premarket June 21

For further details see:

India Globalization stock rises 10% on acquiring rights for potential Alzheimer’s drug compound
Stock Information
Company Name: India Globalization Capital Inc.
Stock Symbol: IGC
Market: NYSE
Website: igcinc.us
Menu
IGC IGC Quote IGC Short IGC News IGC Articles IGC Message Board
Get IGC Alerts

News, Short Squeeze, Breakout and More Instantly...